|
Post by kc on Apr 8, 2017 11:10:15 GMT -5
You want the facts of how the game is played read this 60 page informative letter to the SEC by CREW in 2012 . crew.3cdn.net/f55aefe37e78fb8d0f_z2m6b08ki.pdf This is a history of why we are in such desperate shape today. It goes back to 2010. Martin Shrekili
|
|
|
Post by kc on Apr 7, 2017 16:45:17 GMT -5
Shareholders of record March 27, 2017 can vote.
|
|
|
Post by kc on Apr 7, 2017 15:28:11 GMT -5
something is up. or is it just general house keeping.
Makes for an exciting weekend game of Pins and needles. You just never know what might happen one pre-market Monday morning. We will see SHORTLY.
|
|
|
Post by kc on Apr 7, 2017 15:24:18 GMT -5
|
|
|
Post by kc on Apr 7, 2017 10:57:11 GMT -5
That's deep, sportsrancho. For those of us who can't read invisible ink, care to expand your idea -or did the pop leave you speechless? It was evidently a re-edit or deletion of her posting on the scripts. no issue on my part. she deleted her comments but not the post.
|
|
|
Post by kc on Apr 7, 2017 10:44:20 GMT -5
Very odd we are still at 30 cents presplit. I am usually one that come across negative, but I'd expect the sp to about double today you have to give this about 4 to 8 weeks of progressive increasing scripts to see the PPS start to climb. Today's number might just be a fluke. (as it turns out it was a fluke by a mis posting by Ripano.)
|
|
|
Post by kc on Apr 6, 2017 15:44:39 GMT -5
That's very kind of you. The reality is Matt is failing. In my experience company have almost zero loyalty to their shareholders. If Matt thinks a BK will solve their problems he'd do it 'in a blink of an eye'. The problem with a BK is reduced credibility, and the need for a new source of funding. Afrezza isn't selling partly because of MannKind's low credibility to maintain supply. MannKind can't afford to have their credibility drop any lower, so a BK will be put off as long as possible.
That may be a bad thing (long term) for patents and investors (the crazy ones that are still averaging down). Instead we'll limp along until BK becomes inevitable. I say inevitable because I don't see a marketing effort... Selling the company is much better than filing bankruptcy. Once you file bankruptcy you again create the situation and perception that the product is going to go away or be discontinued.
Where is the board of directors? Sell the company or a partial interest in it to somebody who can take MannKind and Afrezza to the next level.
|
|
|
Post by kc on Apr 6, 2017 12:41:23 GMT -5
I took a loss last September that was offset by a very health gain. So I did a wash but then got back in as I believed we had seen the worst. I have faith that Mike C is doing all he can with the resources that he has available. But eventually they run out in 2017 if they don't get some traction in the new term.
|
|
|
Post by kc on Apr 6, 2017 11:28:58 GMT -5
Well, what if Matt had a buyout offer for say, $11 share, would you rather that he take the safe play and get half of your money back or would you rather they continue to go it alone, even if the chances of bankruptcy were 80%? Sell the company
|
|
|
Post by kc on Apr 6, 2017 11:23:01 GMT -5
Wow. I have a doctoral degree in a health-related field and I have never researched anything more in my life than the prospects for Afrezza and other future inhalable Technosphere drugs. I am amazed at how badly I missed. While I will recover financially eventually; I will never recover psychologically. Many of us are in the same situation. Great product but no money to get it properly in the hands of needing patients. I wish that the Board would have sold the company. It might be too late for us common shareholders. Biggest loss I have even taken and it kept sucking me in to buy more. The Product is a game changer but the Paradigm is too big of a hurdle to get into the market place without capital to advertise.
|
|
|
Post by kc on Mar 29, 2017 21:14:55 GMT -5
So sell your worthless shares and move on? IF it's true that you are so deep underwater here as you claim than why do you continue to waste your time posting here? Are you hoping for a turnaround - and if so why do you never post any actual constructive ideas on what the company should be doing to restore shareholder value as many other posters do? Or you can admit that it would financially benefit you for this company to fail. At least it would make sense as to why you continue to spend your time here. You can have your opinions and i will respect them but be honest with your intentions. It is a fallacy to think that things posted here affect anything at the company. Comments about what they "could" do are not actually constructive if by that you mean helping improve the company's prospects. "Positive" or "hopeful" postings here may help make shareholders feel better about their holdings, but they aren't going to change anything for the company. I can understand why you might be upset with someone that doesn't participate in helping to turn around the company through suggestions here... if not for the fact it is a flawed notion that we have any ability to change the course of the company by posting our hopes and dreams. Who the hell listens to a lizard with yellow lips.
|
|
|
Post by kc on Mar 22, 2017 8:54:43 GMT -5
Finally - the new dosing instructions for the new label from the clamp studies. I would have liked it better if they went stronger after metformin and said just throw it in the trash as it will just mess up proper liver function. Now, the next step are the associated computer models which take all this info on dosing and marry it with real time data from the CGMs and tell the PWD how to dose so they don't need to read all that "label" stuff and figure it out on their own. What did Josh Riff say at the Digital Diabetes Congress the other week about the future - easy ways to tell PWD how to dose and a new way to take insulin. Sehey, The problem with your idea is that Metformin cost nothing so Doctors/Insurance companies use it as its cheap.
|
|
|
Post by kc on Mar 22, 2017 8:52:13 GMT -5
With all the places he checked.. How many Afrezza scripts were being filled? And has anyone else asked at their pharmacy? I live in a backwards state. I called the university and large endo's in the metropolis a year and a half ago, none of them were prescribing afrezza. I think I know the answer in this location. We like to delude ourselves here and think we are above the rest. The random sample we have is good, because it was a San Diego pharmacy? California seems to be ahead of the rest of us. I see your point so many times over sports. Believe me. (Don't ask, don't tell) Let's see what healthcare becomes after the changes from hell to increase the returns of the private health insurance industry paid for in political campaign donations and hate. I will stop.
Peppy, Sadly your correct. Our only hope is that Afrezza gets enough viral visibility and patients demand their doctors prescribe it. That is why the company needs to really watch their dollars and investment wisely on getting seen by the public. Being cash strapped does not help them get the job done. They need something big to happen so they get the cash they need to be seen. Chicken or Egg. Which comes first. I sure hope that The board and Management can pull a rabbit out of their ? Hat or A_s.....
|
|
|
Post by kc on Mar 21, 2017 9:40:31 GMT -5
Interesting that of the 707,558 shares traded when I took this picture were big blocks.
|
|
|
Post by kc on Mar 17, 2017 9:58:59 GMT -5
Peppy who tweeted what?
|
|